NCT01127165View on ClinicalTrials.gov

Low and High Dose Zonisamide in Children as Monotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2009

Conditions
Epilepsy
Interventions
DRUG

zonisamide low dose group

Initial dose was 2mg/kg/day, increased after 1\~2 weeks to 3\~4mg/kg/day.

DRUG

zonisamide high dose group

Initial dose was 2mg/kg/day, increased after 2\~4 weeks to 6\~8mg/kg/day.

Trial Locations (11)

Unknown

Dongsan Medical Center of Keimyung Univ., Seoul

Gangnam Severance Hospital, Seoul

Inje Univ. Ilsan-Paik Hospital, Seoul

Inje Univ. Sanggye-Paik Hospital, Seoul

Korea Univ. Ansan Hospital, Seoul

Korea Univ. Guro Hospital, Seoul

National Health Insurance Corporation Ilsan Hospital, Seoul

Severance Hospital, Seoul

Soonchunhyang Univ. Cheonan Hospital, Seoul

Soonchunhyang Univ. Hospital, Seoul

Yeungnam University Medical Center, Seoul

All Listed Sponsors
lead

Eisai Korea Inc.

INDUSTRY

NCT01127165 - Low and High Dose Zonisamide in Children as Monotherapy | Biotech Hunter | Biotech Hunter